16. Mike Novotny, Founder and CEO, Medrio
Mike Novotny is the founder and CEO of Medrio. Mr. Novotny applies 20 years of experience in research and software to his eClinical SaaS vision. Prior to founding Medrio, Mr. Novotny was president of ...
3 Juni 202034min
15. David Mace, Co-Founder and CEO, SwiftScale Biologics
David Mace is the Co-founder & CEO of SwiftScale Biologics, a life sciences startup based in San Francisco, California. SwiftScale Biologics accelerates time to market for protein drugs by turning a l...
27 Maj 202029min
14. David Bates, PhD, Co-Founder, Linus Health
David Bates is a scientist, inventor, investor, and entrepreneur. He has co-founded several companies including Linus Health and Bode. He is a founding partner of Tamarisc Ventures and serves on the b...
20 Maj 202034min
13. Stephan Kontos, PhD, Co-Founder and CSO, Anokion
Stephan is a co-Founder and Chief Scientific Officer at Anokion, bringing more than 15 years of research expertise in the fields of immunology, protein engineering, and platform technologies to the co...
13 Maj 202031min
12. Robert Gould, PhD, President & CEO, and Owen Wallace, PhD, CSO, Fulcrum Therapeutics
Robert J. Gould joined Fulcrum as president and CEO at the time of the company’s launch in 2016, bringing over 30 years of experience to the role. Previously, he served as president and CEO of Epizyme...
4 Maj 202033min
11. Controllable cell and gene therapies, Paul Wotton, PhD, CEO, Obsidian Therapeutics
Dr. Paul K. Wotton is the Chief Executive Officer at Obsidian Therapeutics. Obsidian is a biotechnology company pioneering controllable cell and gene therapies to deliver transformative outcomes for p...
27 Apr 202029min
10. Chris Murray, Sr. VP, Technical Operations, Blueprint Medicines
Chris is Sr. Vice President, Technical Operations at Blueprint Medicines. He has over 25 years of commercial and clinical manufacturing experience in the biopharmaceutical industry and has been fortu...
26 Feb 202032min
9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation
Carl P. Decicco is a biopharmaceutical veteran with over 30+ years of experience in the industry. Over the course of his career, Carl has played a central role in the advancement of more than 200 comp...
23 Jan 202027min
